NCT02265900

Brief Summary

The therapeutic effects of exercise in Parkinson's disease (PD) are commonly reported, however the mechanisms are unknown. The purpose of this study is to investigate the potential mechanisms of exercise in the brain for the treatment of PD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Nov 2014

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 16, 2014

Completed
16 days until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2020

Completed
Last Updated

March 17, 2021

Status Verified

March 1, 2021

Enrollment Period

5.4 years

First QC Date

October 11, 2014

Last Update Submit

March 15, 2021

Conditions

Keywords

Positron Emission TomographyDopamineParkinson's Disease

Outcome Measures

Primary Outcomes (1)

  • Change in Dopamine release measured by RAC PET

    4 months

Study Arms (2)

Exercise 1

ACTIVE COMPARATOR

One type of exercise

Other: Exercise

Exercise 2

PLACEBO COMPARATOR

A different type of exercise

Other: Exercise

Interventions

One type of exercise

Exercise 1

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • atypical Parkinson syndrome (progressive supranuclear palsy, multiple system atrophy, drug-induced etc.);
  • significant osteoporosis or arthritis;
  • other neurological disease/complications (e.g. myopathy, stroke, brain lesion, MS);
  • self-reports claustrophobia;
  • history of cancer within 5 years of study participation;
  • high dose of radiation from other procedures within the year;
  • not able to tolerate being off PD medication for up to 24 hours;
  • a female subject who is breast-feeding or pregnant.
  • Subjects who regularly use anti-inflammatories (only excluded for PBR scans).
  • artificial heart valve;
  • brain aneurysm clip;
  • electrical stimulator for nerves or bones;
  • ear or eye implant;
  • implanted drug infusion pump;
  • coil, catheter, or filter in any blood vessel;
  • +15 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pacific Parkinson's Research Centre

Vancouver, British Columbia, V6T 2B5, Canada

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Exercise

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • A.J. Stoessl, MD

    Pacific Parkinson's Research Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Clinical PET

Study Record Dates

First Submitted

October 11, 2014

First Posted

October 16, 2014

Study Start

November 1, 2014

Primary Completion

March 12, 2020

Study Completion

March 12, 2020

Last Updated

March 17, 2021

Record last verified: 2021-03

Locations